Novelion Therapeutics Inc (NVLN.OQ)
16 Mar 2018
* NOVELION THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS
BOSTON A Georgia pediatric cardiologist pleaded guilty on Wednesday to wrongfully disclosing information about his young patients to an Aegerion Pharmaceuticals Inc sales representative seeking to identify potential new users of an expensive cholesterol drug.
* PARTNER THERAPEUTICS INC - HAS ACQUIRED GLOBAL RIGHTS TO DEVELOP, MANUFACTURE, AND COMMERCIALIZE LEUKINE (SARGRAMOSTIM) FROM SANOFI
* NOVELION THERAPEUTICS INC - ANNOUNCED THAT A U.S. DISTRICT COURT JUDGE HAS SENTENCED NOVELION SUBSIDIARY AEGERION PHARMACEUTICALS
BOSTON A federal judge on Tuesday sentenced Aegerion Pharmaceuticals Inc for improperly marketing a cholesterol drug and ordered that some of the $40.1 million it agreed to pay to resolve a U.S. investigation go to the company's victims.
BOSTON, Jan 30 A federal judge on Tuesday sentenced Aegerion Pharmaceuticals Inc for improperly marketing a cholesterol drug and ordered that some of the $40.1 million it agreed to pay to resolve a U.S. investigation go to the company's victims.
U.S. JUDGE SENTENCES NOVELION THERAPEUTICS' AEGERION AS PART OF $40 MLN SETTLEMENT -COURT HEARING
BOSTON, Jan 30 Aegerion Pharmaceuticals Inc is set to be sentenced on Tuesday for improperly marketing a cholesterol drug by a judge who rejected an initial plea deal and asked whether the drugmaker should be allowed to "collapse in disgrace."
* NOVELION THERAPEUTICS ANNOUNCES COST REDUCTION PLANS AND CAPITAL STRUCTURE REVIEW
BOSTON Aegerion Pharmaceuticals Inc has asked a U.S. judge to quickly approve a new plea agreement aimed at resolving probes into its promotion of a cholesterol drug, saying its parent company has been blocked from capital markets due to the case's uncertainty.
|Takeda Pharmaceutical Co Ltd (4502.T)||¥5,642||+1.00|
|Pfizer Inc. (PFE.N)||$36.78||+0.20|
|Novartis AG (NOVN.S)||CHF78.00||-0.04|
|Merck & Co., Inc. (MRK.N)||$55.67||+0.42|
|Roche Holding Ltd. (ROG.S)||CHF220.05||-0.75|
|Roche Holding Ltd. (RO.S)||CHF219.80||-5.20|
|Bayer AG (BAYGn.DE)||€95.54||+0.70|
|Bayer AG (BAYE.F)||--||--|
|AstraZeneca plc (AZN.L)||4,867.00||+68.00|
|Allergan, Inc. (AGN.N)||$168.96||+2.84|